Four Biomed IPOs Defy Sector Slump With First-Day Pops

(Bloomberg) -- Four biomedical companies surged in their debuts on Friday after pricing upsized IPOs, despite relative weakness elsewhere in the sector.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.